1. Giau VV, An SS, Bagyinszky E, Kim SY (2015) Next generation sequencing (NGS) gene panels and primers for studies on neurodegenerative disorders. Toxicol Environ Heal Sci 7:S32
2. Lyseng-Williamson KA, Plosker GL (2003) Spotlight on galantamine in Alzheimer’s disease. Disease Manag Health Outcome 11(2):125–128
3. Robinson DM, Plosker GL (2006) Galantamine extended release. CNS Drugs 20(8):673–681
4. Maltz MS, Kirschenbaum HL (2002) Galantamine: a new acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. P&T 27(3):135–138
5. Drug label: REMINYL® (Galantamine HBr), (2001) tablets and oral solution, Food and Drug Administration